247 related articles for article (PubMed ID: 28100174)
41. Intensity of anticoagulation and risk of thromboembolism after elective cardioversion of atrial fibrillation.
Hellman T; Kiviniemi T; Nuotio I; Vasankari T; Hartikainen J; Lip GYH; Airaksinen KEJ
Thromb Res; 2017 Aug; 156():163-167. PubMed ID: 28662483
[TBL] [Abstract][Full Text] [Related]
42. Effect of atrial fibrillation duration on probability of immediate recurrence after transthoracic cardioversion.
Oral H; Ozaydin M; Sticherling C; Tada H; Scharf C; Chugh A; Lai SW; Pelosi F; Knight BP; Strickberger SA; Morady F
J Cardiovasc Electrophysiol; 2003 Feb; 14(2):182-5. PubMed ID: 12693502
[TBL] [Abstract][Full Text] [Related]
43. Trends in the use of electrical cardioversion for atrial fibrillation: influence of major trials and guidelines on clinical practice.
Alegret JM; Viñolas X; Romero-Menor C; Pons S; Villuendas R; Calvo N; Pérez-Rodon J; Sabaté X;
BMC Cardiovasc Disord; 2012 Jun; 12():42. PubMed ID: 22708978
[TBL] [Abstract][Full Text] [Related]
44. Angiotensin II blockade, YKL-40 and maintenance of sinus rhythm after electrical cardioversion for atrial fibrillation.
Tveit A; Seljeflot I; Smith P; Arnesen H; Svendsen JH
Immunobiology; 2013 Oct; 218(10):1256-60. PubMed ID: 23731775
[TBL] [Abstract][Full Text] [Related]
45. Time and frequency recurrence analysis of persistent atrial fibrillation after electrical cardioversion.
Alcaraz R; Rieta JJ
Physiol Meas; 2009 May; 30(5):479-89. PubMed ID: 19369714
[TBL] [Abstract][Full Text] [Related]
46. Clinical predictors and time course of arrhythmia recurrence in patients with early reinitiation of atrial fibrillation after successful internal cardioversion.
Tse HF; Lau CP
Pacing Clin Electrophysiol; 2003 Sep; 26(9):1809-14. PubMed ID: 12930494
[TBL] [Abstract][Full Text] [Related]
47. Persistent atrial fibrillation: a population based study of patients with their first cardioversion.
Lehto M; Kala R
Int J Cardiol; 2003 Dec; 92(2-3):145-50. PubMed ID: 14659845
[TBL] [Abstract][Full Text] [Related]
48. Cardioversion of Atrial Fibrillation (RHYTHM-AF) International Registry in Poland.
Kiliszek M; Opolski G; Włodarczyk P; Dąbrowski R; Ponikowski P
Cardiol J; 2014; 21(5):484-91. PubMed ID: 24526513
[TBL] [Abstract][Full Text] [Related]
49. Five-year follow-up after catheter ablation of persistent atrial fibrillation using the stepwise approach and prognostic factors for success.
Schreiber D; Rostock T; Fröhlich M; Sultan A; Servatius H; Hoffmann BA; Lüker J; Berner I; Schäffer B; Wegscheider K; Lezius S; Willems S; Steven D
Circ Arrhythm Electrophysiol; 2015 Apr; 8(2):308-17. PubMed ID: 25744570
[TBL] [Abstract][Full Text] [Related]
50. Effects of sinus rhythm maintenance on left heart function after electrical cardioversion of atrial fibrillation: implications for tachycardia-induced cardiomyopathy.
Zimmermann AJ; Bossard M; Aeschbacher S; Schoen T; Voellmin G; Suter Y; Lehmann A; Hochgruber T; Pumpol K; Sticherling C; Kühne M; Conen D; Kaufmann BA
Can J Cardiol; 2015 Jan; 31(1):36-43. PubMed ID: 25547548
[TBL] [Abstract][Full Text] [Related]
51. Long-term sinus rhythm maintenance after cardioversion of persistent atrial fibrillation: is the treatment's success predictable?
Kosior DA; Szulc M; Opolski G; Torbicki A; Rabczenko D
Heart Vessels; 2006 Nov; 21(6):375-81. PubMed ID: 17143714
[TBL] [Abstract][Full Text] [Related]
52. Relation of C-reactive protein to long-term risk of recurrence of atrial fibrillation after electrical cardioversion.
Loricchio ML; Cianfrocca C; Pasceri V; Bianconi L; Auriti A; Calo L; Lamberti F; Castro A; Pandozi C; Palamara A; Santini M
Am J Cardiol; 2007 May; 99(10):1421-4. PubMed ID: 17493472
[TBL] [Abstract][Full Text] [Related]
53. Noninvasive time and frequency predictors of long-standing atrial fibrillation early recurrence after electrical cardioversion.
Alcaraz R; Hornero F; Rieta JJ
Pacing Clin Electrophysiol; 2011 Oct; 34(10):1241-50. PubMed ID: 21605132
[TBL] [Abstract][Full Text] [Related]
54. Serial antiarrhythmic therapy: role of amiodarone in prevention of atrial fibrillation recurrence--a lesson from the HOT CAFE Polish Study.
Kosior DA; Opolski G; Wozakowska-Kaplon B; Rabczenko D;
Cardiology; 2005; 104(1):35-44. PubMed ID: 15942183
[TBL] [Abstract][Full Text] [Related]
55. [Atrial fibrillation: always cardioversion? No].
Di Pasquale G; Biancoli S; Sassone B; Pancaldi LG
Ital Heart J Suppl; 2002 Jan; 3(1):81-90. PubMed ID: 11899578
[TBL] [Abstract][Full Text] [Related]
56. Outcomes after nonemergent electrical cardioversion for atrial arrhythmias.
Steinberg BA; Schulte PJ; Hofmann P; Ersbøll M; Alexander JH; Broderick-Forsgren K; Anstrom KJ; Granger CB; Piccini JP; Velazquez EJ; Shah BR
Am J Cardiol; 2015 May; 115(10):1407-14. PubMed ID: 25784514
[TBL] [Abstract][Full Text] [Related]
57. Statins and amiodarone improve freedom from recurrence of atrial fibrillation after successful cardioversion.
Naji F; Suran D; Kanic V; Vokac D; Sabovic M
Med Sci Monit; 2009 Sep; 15(9):CR494-8. PubMed ID: 19721402
[TBL] [Abstract][Full Text] [Related]
58. Comparison of recurrence rates after direct-current cardioversion for new-onset atrial fibrillation in patients receiving versus those not receiving rhythm-control drug therapy.
Li H; Riedel R; Oldemeyer JB; Rovang K; Hee T
Am J Cardiol; 2004 Jan; 93(1):45-8. PubMed ID: 14697464
[TBL] [Abstract][Full Text] [Related]
59. Factors influencing long term persistence of sinus rhythm after a first electrical cardioversion for atrial fibrillation.
Duytschaever M; Haerynck F; Tavernier R; Jordaens L
Pacing Clin Electrophysiol; 1998 Jan; 21(1 Pt 2):284-7. PubMed ID: 9474689
[TBL] [Abstract][Full Text] [Related]
60. Systematic electrocardioversion for atrial fibrillation and role of antiarrhythmic drugs: a substudy of the SAFE-T trial.
Singh SN; Tang XC; Reda D; Singh BN
Heart Rhythm; 2009 Feb; 6(2):152-5. PubMed ID: 19187902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
